---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000495"
form_type: "8-K"
ticker: "VANI"
cik: "0001266806"
company_name: "Vivani Medical, Inc."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:42:35.603561+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vivani Medical raises $8.25M in private placement led by Chairman; extends cash runway into Q2 2026

## Summary
- Issued 7,366,071 shares at $1.12 each to an entity beneficially owned by Chairman Gregg Williams.
- Gross proceeds of ~$8.25M; no warrants, discounts, or placement agent fees incurred.
- Funding expected to extend cash runway into Q2 2026 and accelerate NPM-139 (semaglutide) implant development.
- Placement occurs over multiple closings through January 15, 2026, under Rule 506/Regulation D.

## SEC filing metadata
- accession: 0001753926-25-000495
- form_type: 8-K
- ticker: VANI
- cik: 0001266806
- company_name: Vivani Medical, Inc.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1266806/000175392625000495/0001753926-25-000495-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1266806/000175392625000495/vani-20250326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000495
- JSON: https://secwatch.observer/filing/0001753926-25-000495.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000495.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.